Schistosoma Mansoni Antigen Sm-P80: Prophylactic Efficacy Using TLR4 Agonist Vaccine Adjuvant Glucopyranosyl Lipid A-Alum in Murine and Non-Human Primate Models
Journal of Investigative Medicine - United States
doi 10.1136/jim-2018-000786
Full Text
Open PDFAbstract
Available in full text
Date
July 10, 2018
Authors
Publisher
BMJ